Copeptin, procalcitonin and routine inflammatory markers-predictors of infection after stroke
- PMID: 23118979
- PMCID: PMC3485149
- DOI: 10.1371/journal.pone.0048309
Copeptin, procalcitonin and routine inflammatory markers-predictors of infection after stroke
Abstract
Background: Early predictors for the development of stroke-associated infection may identify patients at high risk and reduce post-stroke infection and mortality.
Methods: In 383 prospectively enrolled acute stroke patients we assessed time point and type of post-stroke infections (i.e. pneumonia, urinary tract infection (UTI) other infection (OI)). Blood samples were collected on admission, and days 1, and 3 to assess white blood cells (WBC), monocytes, C-reactive protein (CRP), procalcitonin (PCT), and copeptin. To determine the magnitude of association with the development of infections, odds ratios (OR) were calculated for each prognostic blood marker. The discriminatory ability of different predictors was assessed, by calculating area under the receiver operating characteristic curves (AUC). Prognostic models including the three parameters with the best performance were identified.
Results: Of 383 patients, 66 (17.2%) developed an infection after onset of stroke. WBC, CRP, copeptin and PCT were all independent predictors of any infection, pneumonia and UTI developed at least 24 hours after measurements. The combination of the biomarkers WBC, CRP and copeptin (AUC: 0.92) and WBC, CRP and PCT (AUC: 0.90) showed a better predictive accuracy concerning the development of pneumonia during hospitalization compared to each marker by itself (p-Wald <0.0001).
Conclusion: Among ischemic stroke patients, copeptin, PCT, WBC and CRP measured on admission were predictors of infection in general, and specifically for pneumonia and UTI within 5 days after stroke. The combination of these biomarkers improved the prediction of patients who developed an infection.
Conflict of interest statement
References
-
- Chamorro A, Horcajada JP, Obach V, Vargas M, Revilla M, et al. (2005) The Early Systemic Prophylaxis of Infection After Stroke study: a randomized clinical trial. Stroke 36: 1495–1500. - PubMed
-
- Vargas M, Horcajada JP, Obach V, Revilla M, Cervera A, et al. (2006) Clinical consequences of infection in patients with acute stroke: is it prime time for further antibiotic trials? Stroke 37: 461–465. - PubMed
-
- Weimar C, Roth MP, Zillessen G, Glahn J, Wimmer MLJ, et al. (2002) Complications following acute ischemic stroke. Eur Neurol 48: 133–140. - PubMed
-
- Chamorro A, Urra X, Planas AM (2007) Infection after acute ischemic stroke: a manifestation of brain-induced immunodepression. Stroke 38: 1097–1103. - PubMed
-
- Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES (2000) The sympathetic nerve–an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev 52: 595–638. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
